The technology underpinning the Bio-Stream pathogen detection platform is unique at multiple levels.

  • Proprietary synthetic antibodies for whole virus detection
  • Virtually instantaneous results with fast antibody binding
  • High accuracy
  • Low cost consumables
  • Powered by Artificial Intelligence
  • Architected on APIs allowing seamless integration
  • Data is captured on a trusted data platform
  • Affordable monthly pricing models

On-site, proactive screening for pathogens such as the SARS-CoV-2 virus is only feasible when testing can be done in a way that makes it easy to incorporate into the corporate health and safety culture – with minimum disruption to the workflows.

Our Technology

Bio-Stream’s screening test stands alone against current market leaders because of its accuracy, speed and low cost. It offers high sensitivity and specificity, yet delivers results faster than other tests of that caliber on the market today.

Bio-Stream’s screening test is being developed specifically for corporate enterprises and other organizations that need to routinely screen large numbers of people for the purposes of maintaining workplace health and safety.

To establish a regular and ongoing screening program at any workplace, a testing platform would have to be:

Simple to use
Capable of full data capture
Able to integrate with other third party IT systems